bf/NASDAQ:HEPA_icon.jpeg

COM:HEPIONPHARMA

Hepion Pharmaceuticals

  • Stock

Last Close

0.69

22/11 21:00

Market Cap

4.62M

Beta: -

Volume Today

19.61K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-5.28M
-
-14.35M
171.70%
-17.00M
18.47%
-14.89M
12.40%
-9.45M
36.54%
-7.04M
25.53%
-20.35M
189.23%
-32.72M
60.77%
-42.20M
28.96%
-48.93M
15.94%
depreciation and amortization
1.32K
-
16.36K
1,138.08%
21.52K
31.61%
27.99K
30.05%
18.79K
32.89%
26.74K
42.32%
34.52K
29.09%
86.07K
149.38%
77.46K
10.01%
67.13K
13.34%
deferred income tax
387.90K
-
-4.22M
-
-536K
87.31%
48.32K
109.02%
6.05K
87.48%
1.87M
-
-409.02K
121.86%
stock based compensation
195.23K
-
2.12M
984.99%
901.87K
57.42%
1.70M
88.52%
234.51K
86.21%
66.18K
71.78%
2.38M
3,495.50%
4.67M
96.22%
2.55M
45.32%
1.34M
47.50%
change in working capital
125.43K
-
952.88K
659.70%
3.33M
249.15%
-1.84M
155.32%
-970.48K
47.27%
-826.23K
14.86%
1.63M
297.14%
-5.57M
441.80%
3.15M
156.63%
302.92K
90.39%
accounts receivables
inventory
accounts payables
-317.05K
-
3.04M
1,058.61%
302.92K
-
other working capital
-970.48K
-
-509.19K
47.53%
-1.41M
177.00%
-5.57M
294.72%
-302.92K
-
other non cash items
3.60M
-
1.59M
55.84%
-3.81M
339.74%
-4.17M
9.50%
-4.94M
18.59%
157.28K
103.18%
140K
10.99%
2.31M
1,550%
1.46M
36.97%
6.74M
362.65%
net cash provided by operating activities
-1.36M
-
-9.67M
609.61%
-16.56M
71.16%
-19.17M
15.81%
-15.65M
18.39%
-7.57M
51.65%
-16.17M
113.68%
-31.22M
93.16%
-34.96M
11.97%
-40.89M
16.96%
investments in property plant and equipment
-15.85K
-
-83.27K
425.46%
-6.60K
92.07%
-14.71K
122.76%
-51.47K
-
-87.98K
70.94%
-130.41K
48.22%
-16.34K
87.47%
-14.30K
12.44%
acquisitions net
-495.60K
-
2.19K
-
purchases of investments
sales maturities of investments
other investing activites
2.27K
-
net cash used for investing activites
-15.85K
-
-83.27K
425.46%
-502.21K
503.11%
-14.71K
97.07%
900
106.12%
-51.47K
5,818.78%
-85.79K
66.68%
-130.41K
52.01%
-14.07K
89.21%
-14.30K
1.66%
debt repayment
-450K
-
-10.41K
-
-668.94K
6,325.96%
-2.37M
254.20%
-176.59K
92.55%
-176.59K
0%
common stock issued
3.23M
-
24.66M
-
1.64M
93.37%
7.68M
369.90%
42.87M
457.90%
82.15M
91.65%
4.49M
-
common stock repurchased
-21M
-
dividends paid
-1K
-
other financing activites
334.97K
-
116.28K
-
11.56M
9,839.49%
13.39M
15.88%
188.59K
98.59%
15.86M
-
1K
99.99%
net cash used provided by financing activities
3.11M
-
12.50M
301.97%
19.90M
59.17%
24.77M
24.46%
12.52M
49.43%
18.71M
49.38%
43.05M
130.15%
81.98M
90.40%
-5.14M
106.27%
4.49M
187.49%
effect of forex changes on cash
-47.14K
-
5.02K
110.66%
net change in cash
1.73M
-
2.75M
58.60%
2.84M
3.47%
5.58M
96.38%
-3.12M
155.95%
11.09M
455.29%
26.80M
141.68%
50.62M
88.86%
-40.16M
179.33%
-36.40M
9.35%
cash at beginning of period
86.72K
-
1.82M
1,996.22%
4.56M
151.03%
7.40M
62.25%
5.95M
19.58%
2.83M
52.43%
13.92M
391.56%
40.73M
192.52%
91.35M
124.30%
51.19M
43.96%
cash at end of period
1.82M
-
4.56M
151.03%
7.40M
62.25%
12.98M
75.35%
2.83M
78.18%
13.92M
391.56%
40.73M
192.52%
91.35M
124.30%
51.19M
43.96%
14.79M
71.12%
operating cash flow
-1.36M
-
-9.67M
609.61%
-16.56M
71.16%
-19.17M
15.81%
-15.65M
18.39%
-7.57M
51.65%
-16.17M
113.68%
-31.22M
93.16%
-34.96M
11.97%
-40.89M
16.96%
capital expenditure
-15.85K
-
-83.27K
425.46%
-6.60K
92.07%
-14.71K
122.76%
-51.47K
-
-87.98K
70.94%
-130.41K
48.22%
-16.34K
87.47%
-14.30K
12.44%
free cash flow
-1.38M
-
-9.76M
607.49%
-16.56M
69.76%
-19.19M
15.85%
-15.65M
18.45%
-7.62M
51.32%
-16.25M
113.39%
-31.35M
92.92%
-34.98M
11.55%
-40.90M
16.94%

All numbers in (except ratios and percentages)